ACT Genomics CSO, Dr. Shu-Jen Chen and ASLAN Medical Director, Dr. Chih-Yi Hsieh attended the Taiwan Research-Based Biopharmaceutical and Manufacturers Association (TRPMA) Precision Oncology for Drug Development Seminar from 14:00-17:00 on 9/21. Dr. Shu-Jen Chen delivered a talk named “Promise of Liquid Biopsy in Clinical Development". The event took place at 1F, No. 465-1, Sec. 6, Zhongxiao E. Rd., Nangang Dist.,Taipei City 11557, Taiwan (TRPMA lecture hall).
Welcomed to join us!
More Info: http://www.trpma.org.tw/index.php/en/